Molecular characterization of dipeptidyl peptidase activity in serum -: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides

被引:234
作者
Durinx, C
Lambeir, AM
Bosmans, E
Falmagne, JB
Berghmans, R
Haemers, A
Scharpé, S
De Meester, I
机构
[1] Univ Antwerp, Dept Pharmaceut Sci, B-2610 Antwerp, Belgium
[2] Eurogenet, Tessenderlo, Belgium
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 17期
关键词
attractin; dipeptidyl peptidase IV; CD26; serum protease; type; 2; diabetes;
D O I
10.1046/j.1432-1327.2000.01634.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dipeptidyl peptidase IV (DPPIV, EC 3.4.14.5) is a serine type protease with an important modulatory activity on a number of chemokines, neuropeptides and peptide hormones. It is also known as CD26 or adenosine deaminase (ADA; EC 3.5.4.4) binding protein. DPPIV has been demonstrated on the plasmamembranes of T cells and activated natural killer or B cells as well as on a number of endothelial and differentiated epithelial cells. A soluble form of CD26/DPPIV has been described in serum. Over the past few years, several related enzymes with similar dipeptidyl peptidase activity have been discovered, raising questions on the molecular origin(s) of serum dipeptidyl peptidase activity. Among them attractin, the human orthologue of the mouse mahogany protein, was postulated to be responsible for the majority of the DPPIV-like activity in serum. Using ADA-affinity chromatography, it is shown here that 95% of the serum dipeptidyl peptidase activity is associated with a protein with ADA-binding properties. The natural protein was purified in milligram quantities, allowing molecular characterization (N-terminal sequence, glycosylation type, CD-spectrum, pH and thermal stability) and comparison with CD26/DPPIV from other sources. The purified serum enzyme was confirmed as CD26.
引用
收藏
页码:5608 / 5613
页数:6
相关论文
共 47 条
  • [1] Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain
    Abbott, CA
    McCaughan, GW
    Levy, MT
    Church, WB
    Gorrell, MD
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (03): : 798 - 810
  • [2] Pyrrolidides: Synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV
    Augustyns, KJL
    Lambeir, AM
    Borloo, M
    DeMeester, I
    Vedernikova, I
    Vanhoof, G
    Hendriks, D
    Scharpe, S
    Haemers, A
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (04) : 301 - 309
  • [3] Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors
    Belyaev, A
    Zhang, XM
    Augustyns, K
    Lambeir, AM
    De Meester, I
    Vedernikova, I
    Scharpé, S
    Haemers, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) : 1041 - 1052
  • [4] Dipeptidyl-peptidase IV-β -: Further characterization and comparison to dipeptidyl-peptidase IV activity of CD26
    Blanco, J
    Nguyen, C
    Callebaut, C
    Jacotot, E
    Krust, B
    Mazaleyrat, JP
    Wakselman, M
    Hovanessian, AG
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 256 (02): : 369 - 378
  • [5] KINETICS OF DIPEPTIDYL PEPTIDASE-IV PROTEOLYSIS OF GROWTH HORMONE-RELEASING FACTOR AND ANALOGS
    BONGERS, J
    LAMBROS, T
    AHMAD, M
    HEIMER, EP
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (02) : 147 - 153
  • [6] CD26, let it cut or cut it down
    De Meester, I
    Korom, S
    Van Damme, J
    Scharpé, S
    [J]. IMMUNOLOGY TODAY, 1999, 20 (08): : 367 - 375
  • [7] Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig
    Deacon, CF
    Hughes, TE
    Holst, JJ
    [J]. DIABETES, 1998, 47 (05) : 764 - 769
  • [8] Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26 dipeptidyl peptidase IV (EC 3.4.14.5)
    DeMeester, I
    Vanhoof, G
    Lambeir, AM
    Scharpe, S
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 189 (01) : 99 - 105
  • [9] Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
    Drucker, DJ
    Shi, Q
    Crivici, A
    SumnerSmith, M
    Tavares, W
    Hill, M
    DeForest, L
    Cooper, S
    Brubaker, PL
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (07) : 673 - 677
  • [10] Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions
    Duke-Cohan, JS
    Gu, JJ
    McLaughlin, DF
    Xu, YH
    Freeman, GJ
    Schlossman, SF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) : 11336 - 11341